Filing Details

Accession Number:
0001209191-10-042870
Form Type:
4
Zero Holdings:
No
Publication Time:
2010-08-17 13:00:00
Reporting Period:
2010-08-13
Filing Date:
2010-08-17
Accepted Time:
2010-08-17 14:31:34
SEC Url:
Form 4 Filing
Issuer
Cik Name Symbol Sector (SIC) IRS No
1003642 Impax Laboratories Inc IPXL Pharmaceutical Preparations (2834) 650403311
Insiders
Cik Name Reported Address Insider Title Director Officer Large Shareholder Other
938048 Allen Chao C/O Impax Laboratories, Inc.
30831 Huntwood Ave.
Hayward CA 94544
Yes No No No
Reported Non-Derivative Transactions
Sec. Name Acquisiton - Disposition Date Amount Price Remaning Holdings Equity Swap Involved Form Type Code Nature of Ownership Explanation
Common Stock Acquisiton 2010-08-13 6,200 $16.03 166,200 No 4 P Indirect By Allen Chao and Lee-Hwa Chao Family Trust
Common Stock Acquisiton 2010-08-13 20,000 $16.03 116,000 No 4 P Indirect By Allen Chao Interest, Ltd.
Common Stock Acquisiton 2010-08-13 20,000 $16.03 20,000 No 4 P Indirect By MAL Investment
Equity Swap Involved Form Type Code Nature of Ownership Explanation
No 4 P Indirect By Allen Chao and Lee-Hwa Chao Family Trust
No 4 P Indirect By Allen Chao Interest, Ltd.
No 4 P Indirect By MAL Investment
Reported Non-Derivative Holdings
Sec. Name Remaning Holdings Nature of Ownership Explanation
Common Stock 39,095 Direct
Footnotes
  1. The price reported in Column 4 is a weighted average price. These shares were purchased at prices ranging from $15.90 to $16.07 in multiple transactions. The reporting person undertakes to provide to Impax Laboratories, Inc., any security holder of Impax Laboratories, Inc. or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares purchased at each separate price within the ranges set forth in footnote (1) to this Form 4.